261 related articles for article (PubMed ID: 18456381)
1. Immortalized human urothelial cells as a model of arsenic-induced bladder cancer.
Eblin KE; Bredfeldt TG; Gandolfi AJ
Toxicology; 2008 Jun; 248(2-3):67-76. PubMed ID: 18456381
[TBL] [Abstract][Full Text] [Related]
2. Mitogenic signal transduction caused by monomethylarsonous acid in human bladder cells: role in arsenic-induced carcinogenesis.
Eblin KE; Bredfeldt TG; Buffington S; Gandolfi AJ
Toxicol Sci; 2007 Feb; 95(2):321-30. PubMed ID: 17093206
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.
Nascimento MG; Suzuki S; Wei M; Tiwari A; Arnold LL; Lu X; Le XC; Cohen SM
Toxicology; 2008 Jul; 249(1):69-74. PubMed ID: 18502017
[TBL] [Abstract][Full Text] [Related]
4. Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells.
Sens DA; Park S; Gurel V; Sens MA; Garrett SH; Somji S
Toxicol Sci; 2004 May; 79(1):56-63. PubMed ID: 14976345
[TBL] [Abstract][Full Text] [Related]
5. Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture.
Eblin KE; Bowen ME; Cromey DW; Bredfeldt TG; Mash EA; Lau SS; Gandolfi AJ
Toxicol Appl Pharmacol; 2006 Nov; 217(1):7-14. PubMed ID: 16930658
[TBL] [Abstract][Full Text] [Related]
6. Dietary administration of sodium arsenite to rats: relations between dose and urinary concentrations of methylated and thio-metabolites and effects on the rat urinary bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Chen B; Naranmandura H; Le XC; Cohen SM
Toxicol Appl Pharmacol; 2010 Apr; 244(2):99-105. PubMed ID: 20045014
[TBL] [Abstract][Full Text] [Related]
7. Trivalent arsenicals induce lipid peroxidation, protein carbonylation, and oxidative DNA damage in human urothelial cells.
Wang TC; Jan KY; Wang AS; Gurr JR
Mutat Res; 2007 Feb; 615(1-2):75-86. PubMed ID: 17134727
[TBL] [Abstract][Full Text] [Related]
8. A comparative study of the sub-chronic toxic effects of three organic arsenical compounds on the urothelium in F344 rats; gender-based differences in response.
Shen J; Wanibuchi H; Waalkes MP; Salim EI; Kinoshita A; Yoshida K; Endo G; Fukushima S
Toxicol Appl Pharmacol; 2006 Feb; 210(3):171-80. PubMed ID: 15950995
[TBL] [Abstract][Full Text] [Related]
9. Arsenic-induced bladder cancer in an animal model.
Cohen SM; Ohnishi T; Arnold LL; Le XC
Toxicol Appl Pharmacol; 2007 Aug; 222(3):258-63. PubMed ID: 17109909
[TBL] [Abstract][Full Text] [Related]
10. Monomethylarsonous acid induces transformation of human bladder cells.
Bredfeldt TG; Jagadish B; Eblin KE; Mash EA; Gandolfi AJ
Toxicol Appl Pharmacol; 2006 Oct; 216(1):69-79. PubMed ID: 16806342
[TBL] [Abstract][Full Text] [Related]
11. Subcellular distribution of inorganic and methylated arsenic compounds in human urothelial cells and human hepatocytes.
Dopp E; von Recklinghausen U; Hartmann LM; Stueckradt I; Pollok I; Rabieh S; Hao L; Nussler A; Katier C; Hirner AV; Rettenmeier AW
Drug Metab Dispos; 2008 May; 36(5):971-9. PubMed ID: 18256204
[TBL] [Abstract][Full Text] [Related]
12. Urothelial cells malignantly transformed by exposure to cadmium (Cd(+2)) and arsenite (As(+3)) have increased resistance to Cd(+2) and As(+3)-induced cell death.
Somji S; Zhou XD; Garrett SH; Sens MA; Sens DA
Toxicol Sci; 2006 Dec; 94(2):293-301. PubMed ID: 16980690
[TBL] [Abstract][Full Text] [Related]
13. Effects of co-administration of dietary sodium arsenite and an NADPH oxidase inhibitor on the rat bladder epithelium.
Suzuki S; Arnold LL; Pennington KL; Kakiuchi-Kiyota S; Cohen SM
Toxicology; 2009 Jun; 261(1-2):41-6. PubMed ID: 19397947
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-8 (IL-8) over-production and autocrine cell activation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells.
Escudero-Lourdes C; Wu T; Camarillo JM; Gandolfi AJ
Toxicol Appl Pharmacol; 2012 Jan; 258(1):10-8. PubMed ID: 22015448
[TBL] [Abstract][Full Text] [Related]
15. Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.
Zhang R; Wang L; Garrett SH; Sens DA; Dunlevy JR; Zhou XD; Somji S
Exp Toxicol Pathol; 2016 Oct; 68(9):479-491. PubMed ID: 27531258
[TBL] [Abstract][Full Text] [Related]
16. Toxicity of dimethylmonothioarsinic acid toward human epidermoid carcinoma A431 cells.
Naranmandura H; Ibata K; Suzuki KT
Chem Res Toxicol; 2007 Aug; 20(8):1120-5. PubMed ID: 17630711
[TBL] [Abstract][Full Text] [Related]
17. Experimental models of human bladder carcinogenesis.
Crallan RA; Georgopoulos NT; Southgate J
Carcinogenesis; 2006 Mar; 27(3):374-81. PubMed ID: 16287878
[TBL] [Abstract][Full Text] [Related]
18. Interdependent genotoxic mechanisms of monomethylarsonous acid: role of ROS-induced DNA damage and poly(ADP-ribose) polymerase-1 inhibition in the malignant transformation of urothelial cells.
Wnek SM; Kuhlman CL; Camarillo JM; Medeiros MK; Liu KJ; Lau SS; Gandolfi AJ
Toxicol Appl Pharmacol; 2011 Nov; 257(1):1-13. PubMed ID: 21925530
[TBL] [Abstract][Full Text] [Related]
19. Keratin 6 expression correlates to areas of squamous differentiation in multiple independent isolates of As(+3)-induced bladder cancer.
Cao L; Zhou XD; Sens MA; Garrett SH; Zheng Y; Dunlevy JR; Sens DA; Somji S
J Appl Toxicol; 2010 Jul; 30(5):416-30. PubMed ID: 20186695
[TBL] [Abstract][Full Text] [Related]
20. Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model.
Escudero-Lourdes C; Medeiros MK; Cárdenas-González MC; Wnek SM; Gandolfi JA
Toxicol Appl Pharmacol; 2010 Apr; 244(2):162-73. PubMed ID: 20045430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
